Pharmaids Pharma

{
  "main_header": {
    "sid": 799751,
    "name": "Pharmaids Pharma",
    "stock_name": "Pharmaids Pharma",
    "full_name": "Pharmaids Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/pharmaids-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.91",
    "chg": 0.27,
    "chgp": "0.88%",
    "dir": 1,
    "prev_price": "30.64",
    "mcapval": "109.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524572,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE117D01018",
    "curr_date": "Apr 10",
    "curr_time": "",
    "bse_nse_vol": "3.22 k",
    "exc_status": "Active",
    "traded_date": "Apr 10, 2026",
    "traded_date_str": "2026 04 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pharmaids-pharma-799751-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3935178",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PharmaidsPharma_mojoScore_3935178.png",
        "date": "2026-04-07 10:10:02",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs 28.5 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs285-3924462",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_priceRelatedfactors_3924462.png",
        "date": "2026-03-30 11:19:32",
        "description": "A sharp decline has pushed Pharmaids Pharmaceuticals Ltd to a fresh 52-week low of Rs 28.5 on 30 Mar 2026, marking a significant 61.2% drop from its peak of Rs 73.45 within the last year. This steep fall comes amid a broader market downturn, but the stock’s underperformance far exceeds sector and benchmark indices."
      },
      {
        "title": "Markets Rally, But Pharmaids Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs2905-3919635",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_priceRelatedfactors_3919635.png",
        "date": "2026-03-27 12:47:12",
        "description": ""
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3917905",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_mojoScore_3917905.png",
        "date": "2026-03-26 10:10:14",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3888508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_mojoScore_3888508.png",
        "date": "2026-03-13 10:10:14",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3864244",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_mojoScore_3864244.png",
        "date": "2026-03-02 10:10:21",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low Amidst Continued Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-amidst-continued-weakness-3858293",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PharmaidsPharma_priceRelatedfactors_3858293.png",
        "date": "2026-02-26 14:37:27",
        "description": "Pharmaids Pharmaceuticals Ltd’s shares declined sharply to a new 52-week low of Rs.30 today, marking a significant drop amid a challenging market environment. The stock underperformed its sector and broader indices, reflecting ongoing concerns about the company’s financial health and market position."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.30.56",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs3056-3848403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PharmaidsPharma_priceRelatedfactors_3848403.png",
        "date": "2026-02-20 11:02:05",
        "description": "Pharmaids Pharmaceuticals Ltd has reached a new 52-week low of Rs.30.56, marking a significant decline in its stock price amid broader market gains. The stock underperformed its sector and continues to trade below all key moving averages, reflecting ongoing pressures within the company’s financial and operational metrics."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.34",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs34-3847363",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PharmaidsPharma_priceRelatedfactors_3847363.png",
        "date": "2026-02-19 15:39:25",
        "description": "Pharmaids Pharmaceuticals Ltd has touched a new 52-week low of Rs.34 today, marking a significant decline in its stock price amid broader market volatility and company-specific performance concerns. This level represents a sharp drop from its 52-week high of Rs.75.98, reflecting a year-long downward trajectory for the pharmaceutical firm."
      }
    ],
    "total": 114,
    "sid": "799751",
    "stock_news_url": "https://www.marketsmojo.com/news/pharmaids-pharmaceuticals-799751"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI LODR",
      "datetime": "27-Mar-2026",
      "details": "Sale of entire shareholding held by Adita Bio Sys Private Limited (material subsidiary of the Company) in Siri Labvivo Diet Private Limited a step-down subsidiary resulting in cessation of its subsidiary status w.e.f March 27 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Intimation of Trading Window Closure pursuant to declaration of Audited Financial Results for the quarter and Year ended March 31 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-04-07 10:10:02

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs 28.5 as Sell-Off Deepens

2026-03-30 11:19:32

A sharp decline has pushed Pharmaids Pharmaceuticals Ltd to a fresh 52-week low of Rs 28.5 on 30 Mar 2026, marking a significant 61.2% drop from its peak of Rs 73.45 within the last year. This steep fall comes amid a broader market downturn, but the stock’s underperformance far exceeds sector and benchmark indices.

Read full news article

Markets Rally, But Pharmaids Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-27 12:47:12

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-03-26 10:10:14

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-03-13 10:10:14

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-03-02 10:10:21

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low Amidst Continued Weakness

2026-02-26 14:37:27

Pharmaids Pharmaceuticals Ltd’s shares declined sharply to a new 52-week low of Rs.30 today, marking a significant drop amid a challenging market environment. The stock underperformed its sector and broader indices, reflecting ongoing concerns about the company’s financial health and market position.

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.30.56

2026-02-20 11:02:05

Pharmaids Pharmaceuticals Ltd has reached a new 52-week low of Rs.30.56, marking a significant decline in its stock price amid broader market gains. The stock underperformed its sector and continues to trade below all key moving averages, reflecting ongoing pressures within the company’s financial and operational metrics.

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.34

2026-02-19 15:39:25

Pharmaids Pharmaceuticals Ltd has touched a new 52-week low of Rs.34 today, marking a significant decline in its stock price amid broader market volatility and company-specific performance concerns. This level represents a sharp drop from its 52-week high of Rs.75.98, reflecting a year-long downward trajectory for the pharmaceutical firm.

Read full news article

View All News